Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00576654
Title Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

triple-receptor negative breast cancer

Hodgkin's lymphoma

non-Hodgkin lymphoma

Advanced Solid Tumor

Therapies

Irinotecan

Veliparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale University New Haven Connecticut 06520 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Covenant Medical Center Harrison Saginaw Michigan 48602 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field